- Home
- DNLI vs WNS Comparison
DNLI vs WNS Comparison
Compare DNLI & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- WNS
- Stock Information
- Founded
- DNLI 2013
- WNS 1996
- Country
- DNLI United States
- WNS India
- Employees
- DNLI N/A
- WNS N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- WNS Business Services
- Sector
- DNLI Health Care
- WNS Consumer Discretionary
- Exchange
- DNLI Nasdaq
- WNS Nasdaq
- Market Cap
- DNLI 2.1B
- WNS 2.5B
- IPO Year
- DNLI 2017
- WNS N/A
- Fundamental
- Price
- DNLI $13.89
- WNS $55.22
- Analyst Decision
- DNLI Strong Buy
- WNS Buy
- Analyst Count
- DNLI 15
- WNS 8
- Target Price
- DNLI $33.85
- WNS $63.00
- AVG Volume (30 Days)
- DNLI 1.6M
- WNS 658.2K
- Earning Date
- DNLI 07-31-2025
- WNS 07-17-2025
- Dividend Yield
- DNLI N/A
- WNS N/A
- EPS Growth
- DNLI N/A
- WNS 24.08
- EPS
- DNLI N/A
- WNS 3.71
- Revenue
- DNLI N/A
- WNS $1,314,942,000.00
- Revenue This Year
- DNLI N/A
- WNS $5.56
- Revenue Next Year
- DNLI $335.74
- WNS $9.37
- P/E Ratio
- DNLI N/A
- WNS $15.78
- Revenue Growth
- DNLI N/A
- WNS N/A
- 52 Week Low
- DNLI $10.57
- WNS $42.62
- 52 Week High
- DNLI $33.33
- WNS $72.11
- Technical
- Relative Strength Index (RSI)
- DNLI 45.02
- WNS 34.61
- Support Level
- DNLI $14.19
- WNS $58.50
- Resistance Level
- DNLI $14.88
- WNS $60.13
- Average True Range (ATR)
- DNLI 0.77
- WNS 1.75
- MACD
- DNLI -0.03
- WNS -0.13
- Stochastic Oscillator
- DNLI 34.55
- WNS 10.25
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.